Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Citigroup Downgrades Aerie Pharmaceuticals to Neutral

Citigroup Downgrades Aerie Pharmaceuticals to Neutral

Citigroup analyst Yigal Nochomovitz downgrades Aerie Pharmaceuticals (NASDAQ:AERI) from Buy to Neutral.

August 29, 2022

1 minute read

Citigroup analyst Yigal Nochomovitz downgrades Aerie Pharmaceuticals (NASDAQ:AERI) from Buy to Neutral.

Bruush And Arrive Merge To Advance Last-Mile Delivery With AI, New Entity To List On Nasdaq

December 15, 12:26 PM

Bruush Oral Care Inc. (NASDAQ: BRSH) and Arrive Technology

August 17, 8:21 AM

B of A Securities analyst Koji Ikeda maintains Global E Online (NASDAQ:GLBE) with a Buy and raises the price target from $30 to $40.

March 30, 5:01 PM

Over the past 3 months, 4 analysts have published their opinion on Sunstone Hotel Invts (NYSE:SHO) stock. These…

August 31, 9:40 AM

Deutsche Bank analyst Brad Zelnick maintains CrowdStrike Holdings (NASDAQ:CRWD) with a Buy and raises the price target from $225 to $230.